title: MY APPROACH to treating heart failure with reduced ejection fraction.
authors.affiliation: Distinguished Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Advanced Heart Failure Treatment Program, Sulpizio Cardiovascular Center UCSD Healthcare System, La Jolla, California. Electronic address: bgreenberg@ucsd.edu.
authors.forename: Barry H
authors.initials: BH
authors.lastname: Greenberg
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D058406:Cardiac Resynchronization Therapy / Q000379:methods / Q000706:statistics & numerical data; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data; D004077:Digoxin / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013318:Stroke Volume; D018754:Ventricular Dysfunction / Q000628:therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000451:Mineralocorticoid Receptor Antagonists; D049994:Sodium Potassium Chloride Symporter Inhibitors; D004077:Digoxin